Burleson & Co’s HCA Healthcare HCA Stock Holding History

Burleson & Co’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4	Closed	-$1K	–	464
2022 Q1	$1K	Buy	+4	New	+$1K	﹤0.01%	364

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Burleson & Co's HCA Position: Q2 2022 in Review

Burleson & Co sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 4 shares — an estimated $1K sold.

Burleson & Co first reported a position in HCA in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 883 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

Burleson & Co reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
Burleson & Co sold 4 HCA Healthcare shares in Q2 2022, an estimated $1K.
Burleson & Co first reported a position in HCA Healthcare in Q1 2022 and held it in 1 quarter.
Burleson & Co's HCA Healthcare position peaked at $1K in Q1 2022.
883 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Burleson & Co's 13F filing for Q2 2022, filed 13 Jul 2022.